Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Gut Microbiota and Drug Metabolism
Archana Pant, Tushar Kanti Maiti, Dinesh Mahajan, et al.
Microbial Ecology (2022) Vol. 86, Iss. 1, pp. 97-111
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Emerging issues in probiotic safety: 2023 perspectives
Daniel Merenstein, Bruno Pot, Gregory Leyer, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 189
The regulatory effect of polysaccharides on the gut microbiota and their effect on human health: A review
Hongkun Xue, Beimeng Liang, Yu Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132170-132170
Closed Access | Times Cited: 32
Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases
Mohamed Kamel, Sami Aleya, Majed Alsubih, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 217-217
Open Access | Times Cited: 26
The Profound Influence of Gut Microbiome and Extracellular Vesicles on Animal Health and Disease
Muttiah Barathan, Sook Luan Ng, Yogeswaran Lokanathan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4024-4024
Open Access | Times Cited: 19
The emerging role of the gut microbiota and its application in inflammatory bowel disease
Wang Xiu, Jianhua Peng, Peipei Cai, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117302-117302
Open Access | Times Cited: 17
Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era
Shuaiqi Wang, Dianwen Ju, Xian Zeng
Biomedicines (2024) Vol. 12, Iss. 1, pp. 194-194
Open Access | Times Cited: 16
Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Alejandro Rubio-Zarapuz, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 221-221
Open Access | Times Cited: 15
Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review
Yu Pi, Miaoyu Fang, Yanpin Li, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 2838-2838
Open Access | Times Cited: 9
Altered gut microbial profiles in drug-treated rats with alcoholic heart disease
Siang Wei, Yan Feng, Ai Meng, et al.
Journal of Medical Microbiology (2025) Vol. 74, Iss. 1
Closed Access | Times Cited: 1
Facile Labeling of Gram-Negative Bacteria with NIR-II Fluorescent Nanoprobes for Intestinal Bacteria Imaging
Wenwen Chen, Rong Chen, Yutong Sun, et al.
ACS Omega (2025) Vol. 10, Iss. 2, pp. 2044-2050
Open Access | Times Cited: 1
Drug–Drug Interaction Between Rifampicin and Albuvirtide: A Phase 1, Randomized, Open‐Label Study
Li Zhang, Jun Chen, Xiaoyan Lin, et al.
The Journal of Clinical Pharmacology (2025)
Closed Access | Times Cited: 1
Dietary content and eating behavior in ulcerative colitis: a narrative review and future perspective
Lun‐Xiu Qin, Wenliang Lv
Nutrition Journal (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The Functions of Major Gut Microbiota in Obesity and Type 2 Diabetes
Siman Liu, Zhipeng Tao, Mingyu Qiao, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 167-167
Open Access | Times Cited: 1
The Role of Bacteriophages in the Gut Microbiota: Implications for Human Health
Stephen Chijioke Emencheta, Chinasa Valerie Olovo, Osita C. Eze, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2416-2416
Open Access | Times Cited: 22
Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?
Alexandru Cosmin Pantazi, Mustafa Ali Kassim Kassim, Wassan Nori, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2480-2480
Open Access | Times Cited: 21
Role of short‐chain fatty acids in host physiology
Mingyue Liu, Yubo Lu, Guoyu Xue, et al.
Animal Models and Experimental Medicine (2024) Vol. 7, Iss. 5, pp. 641-652
Open Access | Times Cited: 7
Recent developments in the enzymatic modifications of steroid scaffolds
Huibin Wang, Ikuro Abe
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 18, pp. 3559-3583
Open Access | Times Cited: 6
The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine
Sara Mousa, Muhammad Sarfraz, Walaa K. Mousa
Metabolites (2023) Vol. 13, Iss. 5, pp. 674-674
Open Access | Times Cited: 14
Buds and Bugs: A Fascinating Tale of Gut Microbiota and Cannabis in the Fight against Cancer
Ahmad K. Al-Khazaleh, Kayla Jaye, Dennis Chang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 872-872
Open Access | Times Cited: 5
Evolving interplay between natural products and gut microbiota
Ningning Zhang, Zheng‐Meng Jiang, Shang‐Zhen Li, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175557-175557
Closed Access | Times Cited: 13
Gut Microbiome Integration in Drug Discovery and Development of Small Molecules
Patrick Jimonet, Céline Druart, Stéphanie Blanquet‐Diot, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 4, pp. 274-287
Open Access | Times Cited: 4
Reactive Carbonyl Species Scavenger: Epigallocatechin-3-Gallate
Haiying Luo, Juanying Ou, Junqing Huang
Foods (2024) Vol. 13, Iss. 7, pp. 992-992
Open Access | Times Cited: 4
Gut Microbiota Disruption in Hematologic Cancer Therapy: Molecular Insights and Implications for Treatment Efficacy
Patricia Guevara-Ramí­rez, Santiago Cadena-Ullauri, Elius Paz‐Cruz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10255-10255
Open Access | Times Cited: 4
NRGCNMDA: Microbe-Drug Association Prediction Based on Residual Graph Convolutional Networks and Conditional Random Fields
Xiaoxin Du, Jingwei Li, Bo Wang, et al.
Interdisciplinary Sciences Computational Life Sciences (2025)
Closed Access
Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024
Jieling Liang, Xiaojuan Lin, Xin Liao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top